Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
National Institutes of Health Clinical Center (CC)
Novartis
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Taiho Oncology, Inc.
Assistance Publique - Hôpitaux de Paris
Novartis
Center for International Blood and Marrow Transplant Research
Takeda
Massachusetts General Hospital
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Ossium Health, Inc.
Ossium Health, Inc.
University of Miami
City of Hope Medical Center
Children's Hospital Medical Center, Cincinnati
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Novartis
Center for International Blood and Marrow Transplant Research
NextCure, Inc.
Brown University
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Nantes University Hospital
M.D. Anderson Cancer Center
Institut Claudius Regaud
Fred Hutchinson Cancer Center
University of Arizona
Novartis
University of Iowa
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Incyte Corporation
Constellation Pharmaceuticals
University of Alabama at Birmingham
University of Alabama at Birmingham
Affiliated Hospital of Qinghai University
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Bristol-Myers Squibb
Massachusetts General Hospital
BlossomHill Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
Assiut University